Announcement

Collapse
No announcement yet.

Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy

    Future Med Chem. 2019 Feb 14. doi: 10.4155/fmc-2018-0489. [Epub ahead of print]
    Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy.

    Ju H1, Zhan P1, Liu X1.
    Author information

    KEYWORDS:

    baloxavir; influenza virus; polymerase acidic endonuclease; ?privileged scaffold? re-evolution/refining

    PMID: 30763130 DOI: 10.4155/fmc-2018-0489
Working...
X